InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
+3.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SCHMIDT ERIC THOMAS. Insider active across 3 companies, notably Allogene Therapeutics, Inc.. In total, 10 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €80k. History available since 24 May 2021. The latest transaction was disclosed on 8 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
5,200 shares0Common StockSEC:0001610717-23-000132:0
558,094 shares0Common StockSEC:0001593968-23-000527:0
35,879 shares@ US$5.4737.7% of flowCommon StockSEC:0001737287-23-000024:0
5,200 shares0Common StockSEC:0001567619-22-013110:0
237,358 shares0Common StockSEC:0001214659-22-004371:0
11,469 shares@ US$7.63370.012% mcap26.5% of flowCommon StockSEC:0001214659-22-004084:0
3,617 shares0Common StockSEC:0001567619-21-012591
3,617 shares0Common StockSEC:0001567619-21-012591:0
14,897 shares@ US$18.220.032% mcap73.5% of flowCommon StockSEC:0001214659-21-005926:0
14,897 shares@ US$18.22100.0% of flowCommon StockSEC:0001214659-21-005926
10 of 10 declarations
About SCHMIDT ERIC THOMAS
Eric Thomas Schmidt is a director at Allogene Therapeutics, Inc. and Revolution Medicines, Inc.
